Luigi Zolio

3 weeks ago | tandfonline.com | Luigi Zolio |Hannah Cohen |David Isenberg

ABSTRACTIntroduction Anticoagulation is frequently required for patients with systemic lupus erythematosus (SLE), given their high prevalence of cardiovascular disease and thrombosis, due to the complexity of disease pathophysiology, some overlap with antiphospholipid syndrome (APS), comorbidities, prevalent cardiovascular risk factors and treatment complications.

Mar 31, 2024 | mja.com.au | Prudence A. Francis |Nava Ferdowsi |Luigi Zolio

Med J Aust 2024; 220 (6): . || doi: 10.5694/mja2.52237 Published online: 1 April 2024 A 64‐year‐old woman presented with non‐neutropenic fever and back pain one day after the first cycle of neoadjuvant chemotherapy (doxorubicin–cyclophosphamide) for locally advanced breast cancer. She had also received pegylated granulocyte colony stimulating factor (PEG‐GCSF) one day after chemotherapy to enable dose‐dense chemotherapy scheduling.